Venture capital fund · 2 deals

Proto Axiom

Sydney, NSW

Disclosed deals

Every published round Proto Axiom took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.

Company	Stage	Announced	Amount	Role	Alongside	Sources
AdvanCell	Series D+	15 Jul 2026	$450m	Participant	Ally Bridge Group Alpha Wave Bain Capital Life Sciences Fidelity T. Rowe Price Qatar Investment Authority (QIA)Sanofi Ventures Brandon Capital Fidelity Management & Research Company Eventide Asset Management Velosity Capital Morningside Eli Lilly and Company SV Health Investors Abingworth SymBiosis Tenmile Piper Heartland Catalio Capital Management Time BioVentures	Startup Daily, Cut Through Venture, Forbes Australia (Mon 12 Oct 2026), Forbes Australia (Thu 3 Sep 2026), Forbes Australia (Thu 16 Jul 2026), Brandon Capital, advancell.com.au, Brandon Capital portfolio, Brandon Capital portfolio, Tenmile portfolio
JumpStart Fertility	Unnamed stage	2025	$4m	Lead	VU Venture Partners	Forbes Australia

Portfolio

Companies Proto Axiom has backed in a published round, and companies whose existing shares it bought off another holder.

Company	What it does	First invested	Rounds	Led
AdvanCell		15 Jul 2026, Series D+	1	0
JumpStart Fertility		2025	1	1

Funds

Fund closes reported for Proto Axiom, as distinct from the investments it has made.

Fund	Announced	Committed	Target	Close	Sources
No fund closes recorded for Proto Axiom yet.

Portfolio companies acquired

Companies Proto Axiom has backed that another company then bought. An exit for the holding, not a deal Proto Axiom did.

Company	Bought by	Kind	Announced	Price
No portfolio company of Proto Axiom is recorded as having been acquired.

Name	Role	Sources
Anthony Liveris	CEO	Forbes Australia

Coverage

Stories naming Proto Axiom. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

12 deals

Brandon Capital's $60m taypayer-funded biotech bets

Brandon Capital has put roughly $60 million of National Reconstruction Fund money into ten biotech companies and warns R&D tax changes would hurt deep tech; portfolio company Myricx Bio went to Novartis.

Also australiatimes.com

Unnamed stage $4m

Birth rates are plummeting globally — this Australian IVF trial wants to change that

Proto Axiom has put $4 million into Sydney IVF biotech JumpStart Fertility, a UNSW spin-out, to pay for human trials of a treatment aimed at age-related fertility decline.

Forbes Australia Thu 3 Jul 2025 JumpStart Fertility University of Queensland UNSW Sydney Proto Axiom Anthony Liveris Dr Lindsay Wu

8 deals

University of Sydney launches $25 million pre-Seed fund for its home-grown startups

The University of Sydney has launched a $25 million pre-seed fund to back ventures spun out of its research, naming five initial investments across carbon capture, diabetes treatment, inhaled medicines and cardiovascular devices.

Startup Daily Mon 5 May 2025 Endo Axiom ProKardia Medical Research Future Fund Net Zero Institute Proto Axiom The University of Sydney CUREator MTPConnect Professor Deanna D'Alessandro Prof Gemma Figtree Professor Julie Cairney Dr Nicholas Hunt

Funding announcement

FUNDED April 2023

Techboard's monthly roundup counts 40 Australian startup raises worth $498m in April 2023, headlined by Saluda Medical and Eucalyptus, plus smaller rounds and fund closes by Purpose Ventures and Proto Axiom.

Something wrong? Tell us